| Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120) |
|---|
| 04/16/2009 | US20090099159 Method of Treating Diseases and Conditions Associated with an Altered Level of Amyloid Beta Peptides and New Enolcarboxamide Compounds |
| 04/15/2009 | EP2046803A1 Imidazothiazole derivatives as mark inhibitors |
| 04/15/2009 | EP1719773B1 Fused heterotetracyclic compounds and use tehreof as hcv polymerase inhibitor |
| 04/15/2009 | CN101410394A HIV inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines |
| 04/15/2009 | CN101410393A Novel heteroaryl substituted benzothiazoles |
| 04/15/2009 | CN101410390A Hydantoin compounds for the treatment of inflammatory disorders |
| 04/14/2009 | US7517995 Thiazolyl-dihydro-cyclopentapyrazole |
| 04/14/2009 | US7517910 Alkoxyphenylpropanoic acid derivatives |
| 04/14/2009 | CA2409841C Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 04/09/2009 | WO2009022311A3 1,2-diamido-ethylene derivatives as orexin antagonists |
| 04/09/2009 | WO2009010694A3 Dyeing method using a styryl- or imine-type disulfide/thiol compound and stimuli, composition and device for implementing same |
| 04/09/2009 | US20090093474 Thiazolyl-dihydro-indazole |
| 04/09/2009 | US20090093465 Therapeutic kinase modulators |
| 04/09/2009 | CA2701630A1 Quinolone analogs and methods related thereto |
| 04/08/2009 | EP2045253A1 a-AMINO ACID DERIVATIVE AND PHARMACEUTICAL COMPRISING THE SAME AS ACTIVE INGREDIENT |
| 04/08/2009 | EP2044086A2 Thiazolopyrimidine modulators of trpv1 |
| 04/08/2009 | EP2044077A1 Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones |
| 04/08/2009 | EP2044061A2 Benzothiophene inhibitors of rho kinase |
| 04/08/2009 | EP1448566B3 Chemokine receptor antagonists and methods of use thereof |
| 04/08/2009 | EP1212299B1 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
| 04/08/2009 | CN101405268A Amide derivatives and their application for the treatment of g protein related diseases |
| 04/08/2009 | CN100475778C Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 04/07/2009 | US7514448 Azaindoles useful as inhibitors of rock and other protein kinases |
| 04/07/2009 | US7514440 angiogenesis inhibitors; as antitumor agents; kinase inhibitors like vascular endothelial growth factor receptors antagonists |
| 04/07/2009 | US7514422 To treat obesity, schizophrenia, anxiety, depression, alcoholism; using 3-benoazepine compounds like 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine (lorcaserin); serotonin 2c receptor agonists |
| 04/02/2009 | WO2009042607A1 Thiazolopyrimidine p13k inhibitor compounds and methods of use |
| 04/02/2009 | WO2009042485A1 Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor biological activity |
| 04/02/2009 | WO2009040552A2 Substituted imidazo (2, 1-b) -1, 3, 4-thiazole compounds, their pharmaceutical compositions and uses thereof |
| 04/02/2009 | WO2009039944A1 Phenothiazine derivative having a double bond, method for the production thereof, and use thereof as a pharmaceutical |
| 04/02/2009 | US20090088450 5-ht7 receptor antagonists |
| 04/02/2009 | US20090088423 Methods and compositions for treating bacterial infections and diseases associated therewith |
| 04/02/2009 | US20090088420 Compounds with hiv-1 integrase inhibitory activity and use thereof as anti-hiv/aids therapeutics |
| 04/02/2009 | US20090088368 Compositions comprising them as ppar modulators |
| 04/02/2009 | CA2704711A1 Thiazolopyrimidine p13k inhibitor compounds and methods of use |
| 04/02/2009 | CA2700539A1 Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor biological activity |
| 04/02/2009 | CA2699328A1 Pyrrolidines and piperidines as orexin receptor antagonists |
| 04/01/2009 | EP2042168A1 Inhalation device comprising phenethanolamine derivatives for treatment of respiratory diseases |
| 04/01/2009 | EP1856132B1 Process for preparing substituted benzothiazinoindoles |
| 04/01/2009 | CN100473651C Pyrazolyl-substituted heterocycles and use thereof as phytosanitary products |
| 03/31/2009 | US7511057 Triazolopyridinylsulfanyl derivatives as p38 MAP kinase inhibitors |
| 03/31/2009 | US7511035 6-{[(2-{4-[3-fluoro-6-(methyloxy)-1,5-naphthyridin-4-yl]-1-piperazinyl}ethyl)amino]methyl}-2H-pyrido[3,2-b][1,4]thiazin-3-one; bacterial infections; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli |
| 03/26/2009 | WO2009038913A2 Isothiazolopyridinones useful for the treatment of (inter alia) cystic fibrosis |
| 03/26/2009 | WO2009038757A2 Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith |
| 03/26/2009 | WO2009037001A2 Novel tetrahydrofusedpyridines as histone deacetylase inhibitors |
| 03/26/2009 | WO2009016564A3 2-aza-bicyclo[3.3.0]octane derivatives |
| 03/26/2009 | WO2009016560A3 Trans-3-aza-bicyclo[3.1.0]hexane derivatives |
| 03/26/2009 | US20090082571 Intermediates of 2-substituted carbapenem derivatives and process for production thereof |
| 03/26/2009 | CA2700058A1 Novel tetrahydrofusedpyridines |
| 03/26/2009 | CA2696776A1 Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith |
| 03/26/2009 | CA2696298A1 Modulators of cystic fibrosis transmembrane conductance regulator |
| 03/25/2009 | EP2038280A2 Fused, tricyclic sulfonamide inhibitors of gamma secretase |
| 03/25/2009 | EP2038266A2 Compounds as cannabinoid receptor ligands and uses thereof |
| 03/25/2009 | EP1756063A4 Amido compounds and their use as pharmaceuticals |
| 03/25/2009 | CN101395161A Thiadiazole compounds and their use in phototherapy |
| 03/24/2009 | US7507746 Enantiomer of tenatoprazole and the use thereof in therapy |
| 03/24/2009 | CA2422380C Pyrazole compounds useful as protein kinase inhibitors |
| 03/24/2009 | CA2264626C Pharmaceutical composition containing lornoxicam and a disodium salt of edta |
| 03/19/2009 | WO2008116107A3 Piperazine derivatives as glucokinase activators |
| 03/19/2009 | WO2008039139A8 Novel 5,7-disubstituted [1, 3] thiazolo [4, 5] pyrimidin-2 (3h)-amine derivatives and their use in therapy |
| 03/19/2009 | WO2008039138A8 Novel 5, 7-disubstituted [1, 3 ] thiazolo [4, 5-d] pyrimidin-2 (3h)-one derivatives and their use in therapy |
| 03/18/2009 | EP2036909A1 Quaternary ammonium salt compounds of spirocyclopiperazines, preparation methods and uses thereof |
| 03/18/2009 | EP2036561A1 Agent for overcoming resistance to anti-cancer agent |
| 03/18/2009 | EP2035436A1 Fused thiazole derivatives as kinase inhibitors |
| 03/18/2009 | EP2035378A1 Substituted isoindoles as bace inhibitors and their use |
| 03/18/2009 | EP2034834A2 PRODRUGS OF 5-AMINO-3-(3'-DEOXY-BETA -D-RIBOFURANOSYL)-THIAZOLO[4,5-d]PYRIMIDIN-2,7-DIONE |
| 03/17/2009 | US7504424 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |
| 03/17/2009 | US7504412 Melanin concentrating hormone receptor antagonists; such as n-(2-cyclopropyl-3-methylimidazo[1,2-a]-pyridin-6-yl)-4-(2-pyridyl)benzamide; central nervous system, cardiovascular and metabolic disorders; synthesis |
| 03/12/2009 | US20090069347 2-phenoxy pyrimidinone analogues |
| 03/12/2009 | US20090068273 Prophylaxis of respiratory disorders such as asthma; composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent; 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol or salt |
| 03/11/2009 | EP2033952A1 Nitrogen-containing Heteroaryl compounds having HIV Integrase Inhibitory Activity |
| 03/11/2009 | EP2032584A2 Thiadiazole compounds and methods of use thereof |
| 03/11/2009 | EP2032583A1 New chemical compounds |
| 03/11/2009 | EP2032577A1 Long wavelength shifted benzotriazole uv-absorbers and their use |
| 03/11/2009 | EP1620440B1 Synthesis of substituted heterocyclic compounds |
| 03/11/2009 | CN101384604A Ethanol or 1,2-ethanediol cyclohexyl antibiotic derivatives |
| 03/11/2009 | CN101384587A Heterocyclic antiviral compounds |
| 03/11/2009 | CN100467467C 2,4-dioxopyrimidine-based mesoionic pigments |
| 03/10/2009 | US7501438 1-(3-naphthalen-1-yl-imidazo[1,5-a]pyridin-1-yl)-butan-1-one; chronic pain, an inflammatory disorder, rheumatoid arthritis, multiple sclerosis, osteoporosis and osteoarthritis; cannabinoid receptor ligands |
| 03/10/2009 | US7501430 e.g. 3-{5-[2-({(3R)-1-[(4-chlorophenyl)sulfonyl]piperidin-3-yl}amino)pyrimidin-4-yl]imidazo[2,1-b][1,3]thiazol-6-yl}phenyl carbamate; antiproliferative, anticarcinogenic agent; cell proliferative disorders |
| 03/10/2009 | US7501412 e.g. 4-(1-(2-hydroxyethyl)piperidin-4-yl)-2H-isoquinolin-1-one; poly(ADP-ribose)polymerase inhibitor; nicotinamide nucleotide (NAD) substrate; acute cerebral infarction |
| 03/05/2009 | WO2009028629A1 Heterocyclic compound and use thereof |
| 03/05/2009 | WO2009027746A1 Heterocyclic amides useful for the treatment of cancer and psoriasis |
| 03/05/2009 | WO2008148754A3 Macrocycles and their uses |
| 03/05/2009 | WO2008127274A3 Heterocyclic inhibitors of bacterial peptidyl trna hydrolase and uses thereof |
| 03/05/2009 | US20090062265 6-({4-[(2,3-Dihydro[1,4]dioxino[2,3-c]pyridin-7-ylmethyl)amino]-1-piperidinyl}methyl)-7-fluoro-5,6-dihydro-3H-pyrrolo[1,2,3-de]quinoxalin-3-one; may be formulated for administration in any convenient way for use in human or veterinary medicine |
| 03/05/2009 | CA2696767A1 Heterocyclic amides useful for the treatment of cancer and psoriasis |
| 03/04/2009 | EP2029584A2 2-[3h-thiazol-2-ylidinemethyl]pyridines and related compounds and their use |
| 03/04/2009 | CN101379058A Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases |
| 03/03/2009 | US7498436 Substituted hydroxyethylamines |
| 03/03/2009 | US7498342 Compounds modulating c-kit activity |
| 03/03/2009 | US7498328 Derivatives of sulphonamides, their preparation and use as medicaments |
| 03/03/2009 | US7498327 Indolylalkylamine metabolites as 5-hydroxytryptamine-6 ligands |
| 03/03/2009 | US7498326 Gramnegative and Grampositive bacterial infections; substituted Piperidine derivatives specially optionally substituted pyrido [3,2, -b][1,4] thiazin-yl; 6-({(3R,4S)-3-Fluoro-1-[(R)-2-hydroxy-2-(2-methoxy-quinolin-8-yl)-ethyl]-piperidin-4-ylamino }-methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one; nontoxic |
| 03/03/2009 | CA2258165C N-[4-(heteroarylmethyl)phenyl]-heteroarylamines |
| 02/26/2009 | WO2009026446A2 Hdac inhibitors |
| 02/26/2009 | WO2009026346A1 Thiazolidine compounds, and methods of making and using same |
| 02/26/2009 | WO2009026345A1 Thiazolidinone compounds, and methods of making and using same |
| 02/26/2009 | US20090054495 4-Chloro-2-phenylsulfanyl-phenyl)-4-isopropoxy-benzenesulfonamide; inflammatory bowl disease such as Crohn's disease or Colitis |
| 02/26/2009 | US20090054479 Fused heterocyclic derivatives as ppar modulators |
| 02/26/2009 | US20090054418 8-(2-{cis-4-[(2,3-dihydro[1,4]dioxino[2,3-c]pyridin-7-ylmethyl)amino]-1-hydroxycyclohexyl}ethyl)-2H-chromen-2-one; may be formulated for administration in any convenient way; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli |